Skip to main content

Advertisement

SpringerLink
Log in

ASO Author Reflections: Improved Survival for Stage IV Breast Cancer: Considerations for Surgery in the Era of HER2-Targeted Therapy

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Barbie TU, Golshan M. De novo stage 4 metastatic breast cancer: a surgical disease? Ann Surg Oncol. 2018;25(11):3109–11.

    Article  Google Scholar 

  2. Hayes DF. HER2 and breast cancer—a phenomenal success story. N Engl J Med. 2019;381(13):1284–6.

    Article  Google Scholar 

  3. Mudgway R, Chavez de Paz Villanueva C, Lin AC, Senthil M, Garberoglio CA, Lum SS. The impact of primary tumor surgery on survival in HER2 positive stage IV breast cancer patients in the current era of targeted therapy. Ann Surg Oncol. 2020. https://doi.org/10.1158/1538-7445.AM2019-4873.

  4. 4. National Institutes of Health Clinical Trials. A randomized phase III trial of the value of early local therapy for the intact primary tumor in patients with metastatic breast cancer. https://clinicaltrials.gov/ct2/show/NCT01242800?term=NCT01242800&rank=1. Accessed 3 March 2020.

  5. UMIN Clinical Trials Registry. A randomized controlled trial comparing primary tumor resection plus systemic therapy with systemic therapy alone in metastatic breast cancer (JCOG1017, PRIM-BC). https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006333. Accessed 3 March 2020.

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Division of Surgical Oncology, School of Medicine, Loma Linda University, Loma Linda, CA, USA

    Ross Mudgway BS & Sharon S. Lum MD

  2. School of Medicine, University of California Riverside, Riverside, CA, USA

    Ross Mudgway BS & Sharon S. Lum MD

Authors
  1. Ross Mudgway BS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sharon S. Lum MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sharon S. Lum MD.

Ethics declarations

Disclosures

The authors have no disclosures. This research did not receive any specific grant from funding agencies from the public, commercial, or not-for-profit sectors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mudgway, R., Lum, S.S. ASO Author Reflections: Improved Survival for Stage IV Breast Cancer: Considerations for Surgery in the Era of HER2-Targeted Therapy. Ann Surg Oncol 27, 2721–2722 (2020). https://doi.org/10.1245/s10434-020-08347-3

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-020-08347-3

Search

Navigation